PSIL · ARCA · ETF
AdvisorShares Psychedelics ETF (PSIL) Price, Holdings & Fees
AdvisorShares Psychedelics ETF (PSIL) closed at $298.22 on Oct 9, 2026, up 1.21% from the previous close of $294.66.
Share price, past year
1Y +13.09%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $298.22 |
| Sep 30, 2026 | $294.22 |
| Aug 31, 2026 | $287.54 |
| Jul 31, 2026 | $284.76 |
| Jun 30, 2026 | $278.83 |
| May 29, 2026 | $270.49 |
| Apr 30, 2026 | $281.69 |
| Mar 31, 2026 | $298.43 |
| Feb 27, 2026 | $293.91 |
| Jan 30, 2026 | $289.81 |
| Dec 31, 2025 | $274.33 |
| Nov 28, 2025 | $270.92 |
| Oct 31, 2025 | $257.52 |
Key statistics
- Expense ratio
- 1.00%
- as of Oct 31, 2025
- Net assets
- $44.4M
- as of Jun 30, 2026
- Holdings
- 32
- as of Jun 30, 2026
- 52-week range
- $256.32 – $299.96
AdvisorShares Psychedelics ETF's expense ratio is 1.00%: $100.00 a year on $10,000 invested.
Holdings
AdvisorShares Psychedelics ETF held 32 investments worth $44.43M as of Jun 30, 2026. Its largest holding was DEFINIUM THERAPEUTICS INC, at 12.85% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | DEFINIUM THERAPEUTICS INCDFTX | 12.85% | $5.71M |
| 2 | COMPASS PATHWAYS PLCCMPS | 11.45% | $5.09M |
| 3 | ATAIBECKLEY INC | 10.47% | $4.65M |
| 4 | RELMADA THERAPEUTICS INCRLMD | 6.84% | $3.04M |
| 5 | NRX PHARMACEUTICALS INCNRXP | 6.07% | $2.70M |
| 6 | NEUROCRINE BIOSCIENCES INCNBIX | 4.38% | $1.95M |
| 7 | CYBIN INCHELP | 4.35% | $1.93M |
| 8 | GH RESEARCH PLCGHRS | 4.31% | $1.92M |
| 9 | ALKERMES PLCALKS | 4.30% | $1.91M |
| 10 | ALTO NEUROSCIENCE INCANRO | 4.20% | $1.87M |
| 11 | ABBVIE INCABBV | 4.14% | $1.84M |
| 12 | BLACKROCK TREASURY TRUST | 3.97% | $1.76M |
| 13 | BRIGHT MINDS BIOSCIENCES INCDRUG | 3.84% | $1.70M |
| 14 | JOHNSON & JOHNSONJNJ | 3.61% | $1.60M |
| 15 | DREY INST PREF GOV MM-M | 3.10% | $1.38M |
| 16 | SUPERNUS PHARMACEUTICALS INCSUPN | 2.89% | $1.28M |
| 17 | NEUPHORIA THERAPEUTICS INCNEUP | 2.49% | $1.11M |
| 18 | NEURONETICS INCSTIM | 2.17% | $965.63K |
| 19 | QUANTUM BIOPHARMA LTDQNTM | 1.66% | $736.90K |
| 20 | OPTIMI HEALTH CORPOPTH | 1.18% | $523.22K |
| 21 | PASITHEA THERAPEUTICS CORPKTTA | 1.09% | $483.21K |
| 22 | SILO PHARMA INCSILO | 1.06% | $469.36K |
| 23 | PSYENCE BIOMEDICAL LTDPBM | 0.84% | $373.88K |
| 24 | INCANNEX HEALTHCARE INCIXHL | 0.52% | $228.86K |
| 25 | NUMINUS WELLNESS INC | 0.47% | $209.08K |
Top 25 of 32 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 95.93% |
| Cash and short-term investments | 7.07% |
| Country | % of fund |
|---|---|
| United States | 57.74% |
| Canada | 25.20% |
| United Kingdom | 11.45% |
| Ireland | 8.61% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, AdvisorShares Psychedelics ETF's total return was +38.67%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +9.78% |
| May 31, 2026 | +8.20% |
| Apr 30, 2026 | +16.74% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- AdvisorShares Psychedelics ETF
- Ticker
- PSIL
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- AdvisorShares Trust
- SEC series ID
- S000072085
- SEC CIK
- 0001408970
- Fractional shares
- Yes
Recent SEC filings
- Aug 21, 2026
- Sep 1, 2026
- Mar 3, 2026
- 485BPOSProspectus updateOct 28, 2025
- Sep 3, 2025
- Mar 4, 2025
- 485BPOSProspectus updateJan 22, 2025
- 485BPOSProspectus updateOct 29, 2024
Shareholder reports and prospectuses are filed by AdvisorShares Trust, the trust behind AdvisorShares Psychedelics ETF, and cover all of its funds.
Frequently asked questions
What is PSIL's price?
AdvisorShares Psychedelics ETF (PSIL) closed at $298.22 on Oct 9, 2026, up 1.21% from the previous close of $294.66.
What is PSIL's expense ratio?
AdvisorShares Psychedelics ETF's expense ratio is 1.00%: $100.00 a year on $10,000 invested.
What does PSIL hold?
AdvisorShares Psychedelics ETF held 32 investments worth $44.43M as of Jun 30, 2026. Its largest holding was DEFINIUM THERAPEUTICS INC, at 12.85% of the fund. Its five largest holdings were DEFINIUM THERAPEUTICS INC, COMPASS PATHWAYS PLC, ATAIBECKLEY INC, RELMADA THERAPEUTICS INC, NRX PHARMACEUTICALS INC.
How has PSIL performed?
Over the 3 months to Jun 30, 2026, AdvisorShares Psychedelics ETF's total return was +38.67%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 21, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Oct 31, 2025. Prices are generated sample data for development. Data sources and disclosures